BP 101 - Ivix

Drug Profile

BP 101 - Ivix

Alternative Names: BP101 - Ivix

Latest Information Update: 30 Aug 2017

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Ivix
  • Class Peptides
  • Mechanism of Action Undefined mechanism
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity Yes

Highest Development Phases

  • Phase II Female sexual dysfunction

Most Recent Events

  • 25 Jul 2017 Ivix LLX completes a phase II trial in Female sexual dysfunction in Russia (Intranasal) (NCT03080298)
  • 22 Feb 2017 Ivix initiates enrolment in a phase I trial in Healthy volunteers in Russia (NCT03102489)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top